For the quarter ending 2025-06-30, CHMX had -$73,434 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
| Net income (loss) | 398,704 | -380,482 | -939,787 |
| Other income received in form shares of stocks | 0 | - | - |
| Prepaid expenses and other assets | 30,673 | - | - |
| Related party advances | -52,437 | 28,000 | 44,207 |
| Prepaid expenses and other assets | - | 60,448 | 457,697 |
| Accounts payable and accrued liabilities | -298,167 | 185,513 | 434,569 |
| Other income received in from shares of stocks | - | 0 | 0 |
| Depreciation and amortization | -38,867 | 38,779 | 77,559 |
| Other expenses paid in stocks | - | 0 | - |
| Unrealized gain on trading securities | -861 | -17,331 | 20,616 |
| Consultant commission paid in third party stock | 0 | 0 | 0 |
| Net proceeds from notes payable | - | -840,000 | 840,000 |
| Net cash provided by (used in) operating activities | 497,566 | -171,307 | -861,765 |
| Repayment of notes payable | 0 | 0 | 0 |
| Net proceeds from convertible notes payable | - | 1,046,000 | - |
| Net proceeds from loan payable | -20,000 | 0 | 20,000 |
| Proceeds from the stock issuance of common stocks | 0 | 0 | 0 |
| Net proceeds from convertible notes payable | 495,000 | - | - |
| Net cash provided by (used in) financing activities | -571,000 | 206,000 | 860,000 |
| Net cash provided by (used in) investing activities | 0 | 0 | 0 |
| Net increase (decrease) in cash | -73,434 | 34,693 | -1,765 |
| Cash and cash equivalents at beginning of period | - | 2,458 | - |
| Cash and cash equivalents at end of period | - | 35,386 | - |
NEXT-ChemX Corporation. (CHMX)
NEXT-ChemX Corporation. (CHMX)